In order to obtain this action we must pay 16,00$ right now, Regenxbio Inc, with address at 9600 BLACKWELL ROAD SUITE 210, ROCKVILLE, Maryland, 20850, United States, is a publicly traded company and its visible heads at the moment are Curran M. Simpson (SVP, Chief Operations & Technology Officer), Kenneth T. Mills (President, Chief Executive Officer & Director), Olivier Danos (Chief Scientific Officer & Senior Vice President), Stephen Pakola (Chief Medical Officer & Senior Vice President), Vit Vasista (Chief Financial Officer & Senior Vice President). Focused on Biotechnology: Biological Products (No Diagnostic Substances) was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 15,59$ - 16,02$, with a percentage difference of 15,81$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.